Acro Biomedical (ACBM) Asset Writedowns and Impairment (2023)
Acro Biomedical (ACBM) posted Asset Writedowns and Impairment of $480000.0 for Q3 2023.
Powered by 
Analysis
Acro Biomedical (ACBM) Asset Writedowns and Impairment (2023) Analysis & Trends
Acro Biomedical has reported Asset Writedowns and Impairment for 1 years, with the latest figure at $480000.0 in Q3 2023.
- On a quarterly basis, Asset Writedowns and Impairment changed N/A year-over-year to $480000.0 in Q3 2023; TTM through Dec 2024 was $480000.0, a N/A change from a year earlier, with the FY2023 full-year figure at $480000.0, changed N/A from the prior year.
- Asset Writedowns and Impairment was $480000.0 for Q3 2023 at Acro Biomedical.
- The five-year high for Asset Writedowns and Impairment was $480000.0 in Q3 2023, with the low at $480000.0 in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - |